Health
‘Stretched’ Vic hospital pleads for staff – Forbes Advocate
An Australian-first trial aims to “once and for all” settle the science surrounding an antimalarial drug touted by US President Donald Trump as protection fro…
An Australian-first trial aims to “once and for all” settle the science surrounding an antimalarial drug touted by US President Donald Trump as protection from COVID-19.
The “COVID shield” study, led by Melbourne’s Walter and Eliza Hall Institute, has recruited more than 100 healthcare workers to test the efficacy of hydroxychloroquine.
Study co-lead Marc Pellegrini said half of study participants would be given the drug and the rest a placebo tablet over a four-month span to determine its eff…
-
Business23 hours agoprofit up 7%, guidance strong
-
Noosa News16 hours agoKatter and pregnant wife crash-land plane in outback Qld
-
Noosa News16 hours agoFollowing Up Hottest 100 of Australian Songs Success with a Second Documentary About Your Life and Career: Jimmy Barnes Talks ‘Working Class Man’
-
Noosa News21 hours agoItalian Film Festival, Brisbane: All the Details